RT Book, Section
A1 Hirji, Sameer A.
A1 Nicastri, Daniel G.
A1 Swanson, Scott J.
A2 Sugarbaker, David J.
A2 Bueno, Raphael
A2 Burt, Bryan M.
A2 Groth, Shawn S.
A2 Loor, Gabriel
A2 Wolf, Andrea S.
A2 Williams, Marcia
A2 Adams, Ann
SR Print(0)
ID 1170410431
T1 VATS Lobectomy and Segmentectomy
T2 Sugarbaker’s Adult Chest Surgery, 3e
YR 2020
FD 2020
PB McGraw-Hill Education
PP New York, NY
SN 9781260026931
LK accesssurgery.mhmedical.com/content.aspx?aid=1170410431
RD 2024/04/19
AB Video-assisted  thoracic  surgery  (VATS)  lobectomy  has  been  used  in  the  treatment  of  resectable  lung  cancer  since  the  early  1990s.  While  substantial  evidence  has  accrued  in  the  literature  to  demonstrate  superiority  of  lobectomy  over  wedge  resection  in  most  patients,  there  are  no  large  prospective,  randomized  studies  favoring  video-assisted  lobectomy  over  conventional  lobectomy  by  thoracotomy.1  There  are  several  large  single  and  multicenter  series  that  support  the  use  of  VATS  lobectomy  technique  over  lobectomy  by  thoracotomy  (Table  73-1).  From  these  data,  as  well  as  data  from  several  exclusive  VATS  series,  it  is  clear  that  VATS  lobectomy  is  technically  feasible  and  safe  and  provides  improved  outcomes  in  terms  of  all  parameters  measured  such  as  morbidity,  mortality,  length  of  stay,  functional  recovery,  and  quality  of  life  in  appropriately  selected  patients  with  resectable  non–small-cell  lung  cancer  (NSCLC).  Even  for  patients  with  locally  advanced  NSCLC  who  undergo  preoperative  chemotherapy,  VATS  lobectomy  is  feasible  and  effective,  without  compromising  oncologic  outcomes.2